CWWeekly »2018 »March »26


Features

Rare Disease Clinical Trials May Require Paradigm Shift Away From Traditional P-Values to More Adaptive Models, Experts Say

Features

FDA Previews Pilot Program to Provide Early Regulatory Review of Innovative Trial Designs

Briefs

House Republicans Pass Right-to-Try Bill

Pipeline

Pipeline new from AstraZeneca, Cavion, Heron and AMO Pharma

Trial Results

Genentech Releases Results for Phase III Lung Cancer Study

CWMarketplace

March Top 10 Industry Provider Profile Page